|1.||Yuki, Nobuhiro: 4 articles (08/2014 - 02/2004)|
|2.||Odaka, Masaaki: 3 articles (06/2012 - 02/2004)|
|3.||Hirata, Koichi: 2 articles (08/2014 - 06/2012)|
|4.||Taguchi, Kyoji: 2 articles (03/2007 - 10/2004)|
|5.||Miyatake, Tadashi: 2 articles (03/2007 - 10/2004)|
|6.||Yoshino, Hiide: 2 articles (03/2007 - 10/2004)|
|7.||Utsunomiya, Iku: 2 articles (03/2007 - 10/2004)|
|8.||Fukami, Yuki: 1 article (08/2014)|
|9.||Yanaka, Chiaki: 1 article (08/2014)|
|10.||Koike, Saiko: 1 article (08/2014)|
05/09/2011 - "Although ganglioside GalNAc-GD1a was first found as a brain ganglioside, IgG autoantibodies to GalNAc-GD1a were subsequently found to be closely related to a human peripheral-nerve disorder, Guillain-Barré syndrome, which is the commonest cause of acute flaccid paralysis worldwide. "
01/01/2007 - "She was diagnosed with GBS on the basis of acute flaccid paralysis, hyporeflexia, nerve conduction studies (reduced amplitude of compound muscle action potentials), and high titers of IgG antibodies to GM1 and GalNAc-GD1a. "
|2.||Abnormal Reflex (Hyperreflexia)
06/01/2012 - "Compared to 190 GBS patients with reduced or absent DTR, the 23 DTR-preserved patients more frequently presented with pure motor limb weakness (87 vs. 47%, p = 0.00026), could walk 5 m independently at the nadir (70 vs. 33%, p = 0.0012), more frequently had antibodies against GM1, GM1b, GD1a, or GalNAc-GD1a (74 vs. 47%, p = 0.014) and were more commonly diagnosed with acute motor axonal neuropathy (65 vs. 34%, p = 0.0075) than with acute inflammatory demyelinating polyneuropathy (13 vs. 43%, p = 0.0011). "
10/15/2004 - "We investigated the epitopes and functional role of IgG anti-GalNAc-GD1a antibodies appearing in serum from a patient with Guillain-Barre syndrome (GBS) and IgG anti-GalNAc-GD1a antibody that was produced by immunization of a rabbit with GalNAc-GD1a. "
|4.||Miller Fisher Syndrome (Fisher Syndrome)
08/01/2006 - "Autoantibodies against GM1b and GalNAc-GD1a are associated with GBS, Fisher syndrome and related conditions. "
12/01/2002 - "In Guillain-Barré syndrome, anti GM1, GM1b, GD1a and GalNAc-GD1a antibodies are found in patients with acute motor axonal neuropathy (AMAN) and anti-GQ1b IgG antibodies are a very sensitive and specific marker for the Miller Fisher syndrome. "
06/01/2002 - "This neuropathy differs from previously reported neuropathy syndromes associated with polyclonal GM2 and GalNAc-GD1a antibodies and from other chronic demyelinating polyneuropathies. "
09/03/2001 - "We describe a patient with a pure motor chronic demyelinating polyneuropathy with an IgM monoclonal component showing anti-GM2, GalNAc-GD1a and GalNAc-GM1b reactivity whose common epitope appears to be -[GalNAcbeta1-4Gal(3-2alphaNeuAc)beta1]. "
09/03/2001 - "IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release."
06/01/2002 - "Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies."
06/01/2002 - "Several polyneuropathy syndromes have been described with polyclonal serum immunoglobulin G (IgG) or immunoglobulin M (IgM) binding to gangliosides GM2 and GalNAc-GD1a that contain the terminal trisaccharide moiety GalNAc(beta1-4)Gal(alpha2-3)NeuAc. "
|2.||Immunoglobulin G (IgG)
|3.||ganglioside M1b (GM1b)
|4.||Immunoglobulin M (IgM)
|6.||Nerve Growth Factor (NGF)
|7.||Neurotransmitter Agents (Neurotransmitter)
|8.||Calcium Channels (Calcium Channel)